Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Buys

Showing results (201-210 of 322) with videos related to

Pageof 33
Sort By:
Journal of the National Cancer Institute|November 30, 2018
Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial RiskMary Beth Terry, Mary B Daly, Kelly Anne Phillips, et al.
Controlled Clinical Trials|February 24, 2001
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening TrialP C Prorok, G L Andriole, R S Bresalier, et al.
Breast Cancer Research : BCR|June 26, 2004
The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancerEsther M John, John L Hopper, Jeanne C Beck, et al.
Health Services Research|June 11, 2025
Importance of Prior Patient Interactions With the Healthcare System to Engaging With Pretest Cancer Genetic Services via Digital Health Tools Among Unaffected Primary Care Patients: Findings From the BRIDGE TrialLingzi Zhong, Jemar R Bather, Melody S Goodman, et al.
Frontiers in Pharmacology|April 24, 2020
Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory DiseaseDaniel P Zimmer, Courtney M Shea, Jenny V Tobin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer riskT S Frank, S A Manley, O I Olopade, et al.
International Journal of Cancer|February 7, 2019
Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study CohortNur Zeinomar, Kelly-Anne Phillips, Mary B Daly, et al.
The Journal of Clinical Investigation|May 9, 2012
Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient miceEmmanuel S Buys, Michael J Raher, Andrew Kirby, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 21, 2016
Androgen-sensitive hypertension associated with soluble guanylate cyclase-α1 deficiency is mediated by 20-HETEAna C Dordea, Sara Vandenwijngaert, Victor Garcia, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 30, 2021
Weight is More Informative than Body Mass Index for Predicting Postmenopausal Breast Cancer Risk: Prospective Family Study Cohort (ProF-SC)Zhoufeng Ye, Shuai Li, Gillian S Dite, et al.
Pageof 33

Showing results (201-210 of 322) with videos related to

Sort By:
Pageof 33
Journal of the National Cancer Institute|November 30, 2018
Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial RiskMary Beth Terry, Mary B Daly, Kelly Anne Phillips, et al.
Controlled Clinical Trials|February 24, 2001
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening TrialP C Prorok, G L Andriole, R S Bresalier, et al.
Breast Cancer Research : BCR|June 26, 2004
The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancerEsther M John, John L Hopper, Jeanne C Beck, et al.
Health Services Research|June 11, 2025
Importance of Prior Patient Interactions With the Healthcare System to Engaging With Pretest Cancer Genetic Services via Digital Health Tools Among Unaffected Primary Care Patients: Findings From the BRIDGE TrialLingzi Zhong, Jemar R Bather, Melody S Goodman, et al.
Frontiers in Pharmacology|April 24, 2020
Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory DiseaseDaniel P Zimmer, Courtney M Shea, Jenny V Tobin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer riskT S Frank, S A Manley, O I Olopade, et al.
International Journal of Cancer|February 7, 2019
Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study CohortNur Zeinomar, Kelly-Anne Phillips, Mary B Daly, et al.
The Journal of Clinical Investigation|May 9, 2012
Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient miceEmmanuel S Buys, Michael J Raher, Andrew Kirby, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 21, 2016
Androgen-sensitive hypertension associated with soluble guanylate cyclase-α1 deficiency is mediated by 20-HETEAna C Dordea, Sara Vandenwijngaert, Victor Garcia, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 30, 2021
Weight is More Informative than Body Mass Index for Predicting Postmenopausal Breast Cancer Risk: Prospective Family Study Cohort (ProF-SC)Zhoufeng Ye, Shuai Li, Gillian S Dite, et al.
Pageof 33